Advance Capital Management Inc. purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 3,152 shares of the financial services provider’s stock, valued at approximately $547,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Solstein Capital LLC bought a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth $25,000. SHP Wealth Management acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in Marsh & McLennan Companies during the 4th quarter worth $27,000. Golden State Wealth Management LLC bought a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $27,000. Finally, Pinnacle Bancorp Inc. acquired a new position in shares of Marsh & McLennan Companies in the first quarter valued at approximately $28,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Down 2.2%
Shares of MRSH opened at $174.57 on Tuesday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $216.32. The firm has a market cap of $84.33 billion, a price-to-earnings ratio of 21.82, a PEG ratio of 2.60 and a beta of 0.61.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on MRSH shares. UBS Group decreased their price target on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research report on Tuesday, June 9th. Piper Sandler reduced their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Mizuho lowered their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, Barclays lowered their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $199.25.
Read Our Latest Stock Report on Marsh & McLennan Companies
Insider Activity
In related news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares in the company, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
- Small-Cap ETFs Poised for Big Growth as Rate Outlook Shifts
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
